Crescita Therpeutc (TSE:CTX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Crescita Therapeutics Inc., a Canadian dermatology company, has revitalized its partnership with a major global skin care company by signing an amended supply agreement worth $US10 million over four years. This agreement, which begins in 2025, will see Crescita manufacturing key products and compensates for previously cancelled orders, while also involving a capital investment by Crescita to upgrade its facilities.
For further insights into TSE:CTX stock, check out TipRanks’ Stock Analysis page.